Robbins LLP reminds investors that a class action lawsuit has been filed against Embecta Corp. on behalf of purchasers of its securities between November 25, 2025 and May 4, 2026. The complaint alleges the medical device company misled shareholders by providing overly optimistic revenue guidance and reaffirming strength in its pen needle segment. On May 5, 2026, Embecta reported it missed second-quarter guidance, slashed its full-year 2026 guidance by 46%, and cut its dividend by 93%, causing the stock to drop over 57% to $3.90 per share. Shareholders seeking to serve as lead plaintiff must file with the court by August 17, 2026.
Embecta CorpEmbecta missed guidance, slashed full-year outlook by 46%, and cut dividend by 93%, triggering a 57% stock drop and a class action lawsuit.